Highlights Brain+ A/S

Equities

BRAINP

DK0061670205

Delayed Nasdaq Copenhagen Other stock markets 04:50:56 2024-05-17 EDT			5-day change	1st Jan Change
0.0944 ^DKK	-5.60%		-7.90%	-51.34%

05-07	Brain+ Plans DKK9 Million Rights Issue to Help Fund Operations	MT
05-07	Brain+ A/S Provides Earnings Guidance for the Year 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brain+ A/S Provides Earnings Guidance for the Year 2024	05-07	CI
Brain+ Teams Up with Quiddity Health to Launch Cognitive Stimulation Therapy Software in UK	02-09	MT
Brain+ A/S Partners with Quiddity Health to Prepare UK Market Entry for CST-Therapist Companion	02-09	CI
Brain+ Bags Two Cognitive Stimulation Therapy Software Supply Deals in Denmark	01-18	MT
Brain+ Signs Two New Danish Sales Contracts on CST-Therapist Companion and Updates on the Product's Commercial Potential	01-18	CI
Brain+ Receives DKK4 Million Grant in Denmark for Digital Therapy Platform for Dementia Support	12-14	MT
Brain+ to Supply Cognitive Stimulation Therapy Software to Care Facilities in Copenhagen, Denmark	12-11	MT
Brain+ A/S Closes Sales Contract with Copenhagen Municipality on CST-Therapist Companion to Support Dementia Care and Therapy	12-11	CI
Brain+ A/S and VIA University College start usability study on CST-Therapist Companion in Denmark	11-14	CI
Nexstim Wins Order for Navigated Brain Stimulation System in Finland	23-10-20	MT
Brain+ A/S Releases New Version of Its Cst-Therapist Companion Dementia Product with Updated User Features	23-10-04	CI
Brain+ Secures Grant to Advance Funding Application for Dementia Therapy Project	23-09-20	MT
Brain+ Wins Intellectual Property Protection for Cognitive Stimulation Therapy Product in UK, EU	23-09-08	MT
Brain+ Secures Intellectual Property Rights for CST-Therapist Companion in the Eu and the United Kingdom	23-09-08	CI
Brain+ A/S Provides Earnings Guidance for the Full Year 2023	23-08-31	CI
Brain+ A/S and Danish Municipality Are Advancing the Development of Version 2.0 of the CST Therapist Companion	23-08-09	CI
Brain+ A/S Announces Breakthrough Alzheimer's Drug Approval Seen to Renew Dementia Drug Investments and Increase the Potential for Digital Dementia Therapeutics	23-07-10	CI
Denmark’s Brain+ Closes Second Sales Contract for Digital Dementia Product	23-05-10	MT
Brain+ A/S Announces Cognitive Stimulation Therapy Enhances the Effects of Alzheimer's Disease Medicine	23-03-24	CI
Brain+ Boosts Sales Contract with Danish Municipality	23-03-20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Brain+ A/S

Equities

BRAINP

DK0061670205

Highlights

Filters